ctDNA Blood Tests for ER+ Breast Cancer Treatment De-escalation
Researchers are evaluating whether circulating tumor DNA (ctDNA) tests, specifically Signatera, can safely reduce aggressive treatments for older women with ER-positive breast cancer. By detecting molecular residual disease, clinicians aim ... Read More